Literature DB >> 8780035

Glutamine synthetase-induced enhancement of beta-amyloid peptide A beta (1-40) neurotoxicity accompanied by abrogation of fibril formation and A beta fragmentation.

M Y Aksenov1, M V Aksenova, D A Butterfield, K Hensley, C Vigo-Pelfrey, J M Carney.   

Abstract

beta-Amyloid peptide (A beta) is the main constituent in both senile plaques and diffuse deposits in Alzheimer's diseased brains. It was previously shown that synthetic A beta s were able to form free radical species in aqueous solution and cause both oxidative damage to cell proteins and inactivation of key metabolic enzymes. We also previously demonstrated that an interaction of A beta (1-40) with the oxidatively sensitive enzyme glutamine synthetase (GS) resulted in both inactivation of GS and an increase of A beta toxicity to hippocampal cell cultures. In the present study the enhancement of A beta toxicity during interaction with GS was found to be accompanied by abrogation of fibril formation and partial fragmentation of A beta (1-40). HPLC elution profiles demonstrated the production of several peptide fragments. Analysis of the amino acid sequence of the major fragments identified them as the first 15 and the last six amino acids of A beta (1-40). The fragmentation of A beta was inhibited by immunoprecipitation of GS.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8780035     DOI: 10.1046/j.1471-4159.1996.66052050.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  11 in total

1.  Neurotoxicity of Alzheimer's disease Aβ peptides is induced by small changes in the Aβ42 to Aβ40 ratio.

Authors:  Inna Kuperstein; Kerensa Broersen; Iryna Benilova; Jef Rozenski; Wim Jonckheere; Maja Debulpaep; Annelies Vandersteen; Ine Segers-Nolten; Kees Van Der Werf; Vinod Subramaniam; Dries Braeken; Geert Callewaert; Carmen Bartic; Rudi D'Hooge; Ivo Cristiano Martins; Frederic Rousseau; Joost Schymkowitz; Bart De Strooper
Journal:  EMBO J       Date:  2010-09-03       Impact factor: 11.598

Review 2.  Activation of microglia and astrocytes: a roadway to neuroinflammation and Alzheimer's disease.

Authors:  Darshpreet Kaur; Vivek Sharma; Rahul Deshmukh
Journal:  Inflammopharmacology       Date:  2019-03-14       Impact factor: 4.473

3.  Serum glutamine synthetase has no value as a diagnostic biomarker for Alzheimer's disease.

Authors:  Yannick Vermeiren; Nathalie Le Bastard; Christopher M Clark; Sebastiaan Engelborghs; Peter P De Deyn
Journal:  Neurochem Res       Date:  2011-05-20       Impact factor: 3.996

Review 4.  The 2013 SFRBM discovery award: selected discoveries from the butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairment.

Authors:  D Allan Butterfield
Journal:  Free Radic Biol Med       Date:  2014-07-01       Impact factor: 7.376

5.  Neuronal expression of splice variants of "glial" glutamate transporters in brains afflicted by Alzheimer's disease: unmasking an intrinsic neuronal property.

Authors:  David V Pow; David G Cook
Journal:  Neurochem Res       Date:  2009-03-25       Impact factor: 3.996

Review 6.  The glutamatergic system and Alzheimer's disease: therapeutic implications.

Authors:  D Allan Butterfield; Chava B Pocernich
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

7.  The free radical antioxidant vitamin E protects cortical synaptosomal membranes from amyloid beta-peptide(25-35) toxicity but not from hydroxynonenal toxicity: relevance to the free radical hypothesis of Alzheimer's disease.

Authors:  R Subramaniam; T Koppal; M Green; S Yatin; B Jordan; J Drake; D A Butterfield
Journal:  Neurochem Res       Date:  1998-11       Impact factor: 3.996

8.  Age-dependent decrease in glutamine synthetase expression in the hippocampal astroglia of the triple transgenic Alzheimer's disease mouse model: mechanism for deficient glutamatergic transmission?

Authors:  Markel Olabarria; Harun N Noristani; Alexei Verkhratsky; José J Rodríguez
Journal:  Mol Neurodegener       Date:  2011-07-30       Impact factor: 14.195

Review 9.  Oxidative Stress, Amyloid-β Peptide, and Altered Key Molecular Pathways in the Pathogenesis and Progression of Alzheimer's Disease.

Authors:  D Allan Butterfield; Debra Boyd-Kimball
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

10.  Lipids revert inert Abeta amyloid fibrils to neurotoxic protofibrils that affect learning in mice.

Authors:  Ivo Cristiano Martins; Inna Kuperstein; Hannah Wilkinson; Elke Maes; Mieke Vanbrabant; Wim Jonckheere; Patrick Van Gelder; Dieter Hartmann; Rudi D'Hooge; Bart De Strooper; Joost Schymkowitz; Frederic Rousseau
Journal:  EMBO J       Date:  2007-12-06       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.